Clinical Trials Browser

Phase 2 × Withdrawn × Sarcoma, Myeloid × Clear all

NCT05854966 2024-09-19

CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 2 Withdrawn

Other hematologic neoplasmSarcoma

Leukemia, Myeloid, Acute, Sarcoma, Myeloid